A Quote by Alex Azar

Patients who face long odds and terminal illnesses do not always have access to the latest drugs in clinical trials. They don't want to give up, but they don't have years to wait for new drugs to receive FDA approval.
My goals over the decade include to develop new drugs to treat intractable diseases by using iPS cell technology and to conduct clinical trials using it on a few patients with Parkinson's diseases, diabetes or blood diseases.
In 15 years, we've raised $225 million, sequenced the myeloma genome, and opened 45 trials of 23 drugs - six approved by the FDA - which have doubled the life span of multiple myeloma patients. I've taken both Velcade and Revlimid, which we helped develop.
In an era of unprecedented medical innovation, we have to do more to ensure that patients facing terminal illnesses have access to potentially life-saving treatments.
When the FDA forces an old drug off the market, patients have very little say in the matter. Patients have even less of a say when the FDA chooses not to approve a new drug. Instead, we are supposed to rely on the FDA's judgment and be grateful. But can the FDA really make a choice that is appropriate for everyone? Of course not.
Consider the clinicaltrials by which drugs are tested in human subjects.5 Before a new drug can enter the market, its manufacturer must sponsor clinicaltrials to show the Food and Drug Administration that the drug is safe and effective, usually as compared with a placebo or dummy pill. The results of all the trials (there may be many) are submitted to the FDA, and if one or two trials are positive—that is, they show effectiveness without serious risk—the drug is usually approved, even if all the other trials are negative.
Scheduling of drugs is a government problem, not our problem. They want to schedule something, that's their problem. My feeling of creation is to make new drugs. They're new drugs, so they're unscheduled. They've never been made before.
The choice is not between drugs and no drugs, but between illegal drugs and legal drugs. Until the 1920s drugs were legal, why not now? Lots of people are on drugs anyway - it is called medication.
Over the years, HIV/AIDS activists and their allies have been pioneers in creating new frontiers in the medical establishment. Through their efforts, the FDA drug approval procedures were reformed so promising new therapies could reach desperate patients quicker.
Most drugs sold in the U.S. are produced outside of the country, and if we can ensure supply-chain safety for these drugs, introducing more of them to the market quicker could mean major differences in the price of drugs, quality of life for patients, and for some Americans the difference between life and death.
Chronotropic Drugs:Drugs engineered to affect one's sense of time. Chronodecelocotropic drugs have no short term effect but over time give one the impression that time feels longer. Chronoaccelocotropic drugs have the opposite effect.
In contrast to how tech firms want to disrupt and break things - developing drugs must be incremental and step-by-step. This is the kind of work that involves people putting their lives on the line every day with clinical trials.
We all want our drugs to be safe - and so an essential part of the pathway to the development of a new drug is approval by a regulator.
Drug use, some might say, is destroying this country. And we have laws against selling drugs, pushing drugs, using drugs, importing drugs. And the laws are good because we know what happens to people in societies and neighborhoods which become consumed by them. And so if people are violating the law by doing drugs, they ought to be accused and they ought to be convicted and they ought to be sent up.
I didn't do drugs, I never did do drugs. Never. I don't have any story of drugs, you know, to speak of. Never did drugs, never was interested in drugs and then I wasn't interested in the people around the drugs.
The war on drugs was an ideology the government came up with, and there never really was a war on drugs. I mean, to stop the importation of drugs into the United States of America is an impossibility.
Treating only terminal cancer patients, the Rand (anti-cancer) vaccine produced objective improvement in 35% of 600 patients while another 30% demonstrated subjective improvement. FDA stopped the vaccine's use in a federal court hearing where neither the cancer patients nor their doctors were allowed to testify.
This site uses cookies to ensure you get the best experience. More info...
Got it!